Päivi Lehtonen starting as Injeq’s new Sales Director in April

The current CEO of Teivo, Päivi Lehtonen, will start as Injeq’s new Sales Director in the beginning of April. Päivi Lehtonen has Master’s degree in Business Administration and she has earlier worked, e.g. as a sales director at Orion Pharma Veterinary Medicines and as CEO of the pharmaceutical company Vetcare Oy and the veterinary clinic chain Univet. All these previous positions have included international sales and growth and so, Lehtonen will now take responsibility for scaling Injeq’s international business. Recruiting an international sales professional complements Injeq’s strategy of growing its medical business in key markets.

We wish Päivi warmly welcome to Injeq team.

Tiedote osakkeenomistajille / Notice to shareholders

TIEDOTE INJEQ OYJ:N OSAKKEENOMISTAJILLE NOTICE TO SHAREHOLDERS OF INJEQ PLC
Read more »

News release on April 12, 2024

The share issue of Injeq Plc. ended on April 5, 2024, and the investment round did not achieve the goals […]
Read more »

Information to shareholders, March 22nd, 2024

Injeq has started a share issue. The maximum of the financing round is set at €3,000,000. If the €2,000,000 goal […]
Read more »

Injeq webinars by Dr Sauli Palmu and Dr Harri Sievänen

Injeq webinar videos are now available! Welcome to participate in Dr. Sauli Palmu’s lecture “Lumbar punctures in pediatric hemato-oncology” (part […]
Read more »

New distributor agreement with “GENFAX SRL”

We are pleased to announce that GENFAX is appointed as INJEQ’s exclusive distributor in Romania. We are confident that our […]
Read more »

Injeq webinar today, Thursday Feb 22nd, 2024

Welcome to the webinar “Innovation in lumbar punctures” on February 22nd, 2024, at 7:00 pm (Madrid time Zone)   Lecturers […]
Read more »